Citius Oncology (CTOR) Change in Inventory (2024 - 2026)

Citius Oncology (CTOR) has 3 years of Change in Inventory data on file, last reported at $20248.0 in Q1 2026.

• On a quarterly basis, Change in Inventory fell 97.89% year-over-year to $20248.0 in Q1 2026; TTM through Mar 2026 was $6.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $12.6 million, up 492.78% from the prior year.
• Change in Inventory for Q1 2026 stood at $20248.0, down from $352649.0 in the prior quarter.
• Over the last five years, Change in Inventory for CTOR reached as high as $6.1 million in Q4 2024 and fell as low as $20248.0 in Q1 2026.
• Historically, Change in Inventory has averaged $2.2 million across 3 years, with a median of $1.4 million in 2025.
• Across the five-year window, Change in Inventory sank 94.23% in 2025 and sank 97.89% in 2026, its largest moves.
• Year by year, Change in Inventory stood at $6.1 million in 2024, then tumbled by 94.23% to $352649.0 in 2025, then tumbled by 94.26% to $20248.0 in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $20248.0 in Q1 2026, $352649.0 in Q4 2025, and $3.7 million in Q3 2025.